Source: WebWire

Press Release: Philips Respironics : FDA Orders Philips Respironics to Notify Patients Regarding the Recall of Certain Breathing Assistance Machines

The U.S. Food and Drug Administration issued a notification order  to Philips Respironics requiring the company to notify patients and others of the company's June 14, 2021, recall of certain Philips Respironics ventilators, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) machines, and the unreasonable risk of substantial harm to the public health posed by the degradation of the polyester-based polyurethane (PE-PUR) sound abatement foam used in thos...Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=286439

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more